VCT

  • HMRC strips Oxford Tech VCTs of status

    HMRC strips Oxford Tech VCTs of status

    In 1999, Oxford Technology VCT invested in Scancell Holdings when it was a start-up company. In December 2003, Oxford Technology 3 VCT invested £150,000 in Scancell and has since made subsequent ‘top up’ investments to support its growth. Aim-listed oncology specialist Scancell has a vaccine for melanoma which is in clinical trials. In August 2013,…

  • ten  verdicts on the Autumn Statement

    ten verdicts on the Autumn Statement

    Reacting on everything from the revisions to the UKs growth outlook to changes to VCT, ISA and tax rules, 12 experts have their say on the Chancellors Autumn Statement.

  • VCT backs ex-military entrepreneurs

    VCT backs ex-military entrepreneurs

    A venture capital trust has been launched specifically to support businesses run by ex-military entrepreneurs.

  • VCT assets hit peak

    VCT assets hit peak

    Assets in venture capital trusts (VCTs) have hit an all-time peak.

  • analysis applause for fca over ucis

    analysis applause for fca over ucis

    The ban on promoting Ucis schemes introduced by the FCA earlier this week has gone by without so much as one man protesting outside the FCA’s headquarters holding a ‘Paint slogan here’ placard.

  • FCA reveals details of Ucis marketing ban

    FCA reveals details of Ucis marketing ban

    Enterprise investment schemes, venture capital trusts and ETFs are among the fund structures exempt from the FCA’s ban on the marketing of Unregulated Collective Investment Schemes (Ucis) to retail investors, much to the relief of industry experts.

  • FSA decision on VCTs REITs ETPs

    FSA decision on VCTs REITs ETPs

    Fund managers have welcomed the news the FSA is re-thinking proposals to restrict the promotion and sale of venture capital trusts (VCTs), real estate investment trusts (REITs) and exchange traded products (ETPs).

  • ucis unregulated but not unnecessary

    ucis unregulated but not unnecessary

    Piers Denne argues that while the FSA may be right in having its spotlight firmly on Ucis propositions, it is wrong to tar all such strategies with the same unfavourable brush.